Process Validation: EU GMP Annex 15 Explained

A process that worked on three batches two years ago is not the same as a process you can trust today. Process validation is how you show, with evidence, that your manufacturing process reliably makes product to its defined quality attributes, batch after batch. This guide explains the EU GMP Annex 15 expectations and the lifecycle approach that has replaced the old one-off validation mindset.

What is process validation?

Process validation is documented evidence that a manufacturing process, operated within defined parameters, consistently produces product meeting its predetermined quality attributes. It is not a single event but an ongoing demonstration of control, from first design through routine commercial production. The goal is assurance, both for you and the regulator, that quality is built into the process rather than tested into the product at the end.

What does EU GMP Annex 15 require?

EU GMP Annex 15, Qualification and Validation, sets the expectations for validating processes, equipment, utilities and systems. It calls for a Validation Master Plan that defines your approach, a risk-based rationale for what you validate and how, and qualified equipment and utilities before process validation begins. Annex 15 sits alongside ICH Q8 to Q11, which bring quality by design and quality risk management into the picture.

What are the three stages of the process validation lifecycle?

The modern approach treats validation as a lifecycle in three stages rather than a single qualification exercise.

This lifecycle view, shared by EU and FDA guidance, replaces the idea that three good batches once meant a process was validated forever.

What is process performance qualification (PPQ)?

PPQ is the stage where you confirm, at commercial scale and with the commercial process, that everything designed in Stage 1 actually delivers. You run a defined number of batches under a pre-approved protocol, with heightened sampling and testing, and you assess the results against acceptance criteria before release for routine production. The number of PPQ batches is justified by risk and prior knowledge rather than fixed at three by default.

How does continued process verification (CPV) work?

CPV is the ongoing stage that many sites underestimate. You trend critical parameters and quality attributes across routine batches to confirm the process stays in a state of control, and you feed signals into your product quality review and change control. A drift that CPV catches early is a deviation avoided later. Weak CPV, where data is collected but never trended, is a common gap an auditor will probe.

What are the common process validation pitfalls?

Most validation problems trace back to a handful of recurring errors.

• Starting PPQ before equipment and utilities are properly qualified.
• Defaulting to three batches with no risk-based justification.
• Critical process parameters that were never genuinely linked to critical quality attributes.
• Treating validation as a one-off, with no real continued process verification.
• A Validation Master Plan that exists on paper but does not match practice.

An independent GMP audit or a readiness review before a licensing inspection is the surest way to find these gaps while you still have time to close them.

Key takeaways

• Process validation is ongoing proof your process reliably meets its quality attributes.
• Annex 15 sets the expectations, and the three-stage lifecycle is the current approach.
• PPQ confirms the design at commercial scale, and CPV proves the process stays in control.
• The batch count is justified by risk, not fixed at three by habit.

If you want your validation strategy reviewed before an inspection, book a discovery call with a senior Qualified Person and GMP auditor.